Session Information

Free Paper

[FP-FR-32] Retinal Vein Occlusion
Go back
print
Day
Apr 04 (Fri)
Time
10:30 - 12:00
Room
Room 25 - Imperial Hotel 3F Tsuru
Topic
Retina - Medical
Chair/Coordinator
Chair)David Brown、Chair)Yuichiro Ogura

Duration 5min, Q&A 3min

FP-FR-32-1 / 

Retina - Medical

Retrospective Study of Two or More Dexamethasone Intravitreal Implant 0.7mg Injections for Retinal Vein Occlusion

Daniel Roth

Retrospective Study of Two or More Dexamethasone Intravitreal Implant 0.7mg Injections for Retinal Vein Occlusion

Duration 5min, Q&A 3min

FP-FR-32-2 / 

Retina - Medical

Ischemia and Reduced Sensitivity in Branch Retinal Vein Occlusion

Hiroyuki Iijima

Ischemia and Reduced Sensitivity in Branch Retinal Vein Occlusion

Duration 5min, Q&A 3min

FP-FR-32-3 / 

Retina - Medical

Hemodynamics of Ischemic Central Retinal Vein Occlusion Using Laser Speckle Flowgraphy

Akiko Kogure

Hemodynamics of Ischemic Central Retinal Vein Occlusion Using Laser Speckle Flowgraphy

Duration 5min, Q&A 3min

FP-FR-32-4 / 

Retina - Medical

Correlation of Precise Area of Peripheral Non-Perfusion with the Ischemic Index in Retinal Vein Occlusion

Srinivas Sadda

Correlation of Precise Area of Peripheral Non-Perfusion with the Ischemic Index in Retinal Vein Occlusion

Duration 5min, Q&A 3min

FP-FR-32-5 / 

Retina - Medical

Two-Year Results of the COPERNICUS Study Evaluating Intravitreal Aflibercept Injection for Macular Oedema Secondary to Central Retinal Vein Occlusion

David Brown

Two-Year Results of the COPERNICUS Study Evaluating Intravitreal Aflibercept Injection for Macular Oedema Secondary to Central Retinal Vein Occlusion

Duration 5min, Q&A 3min

FP-FR-32-6 / 

Retina - Medical

18-Month Results of the GALILEO Study Evaluating Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion

Yuichiro Ogura on Behalf of the Galileo Steering Committee

18-Month Results of the GALILEO Study Evaluating Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion

Duration 5min, Q&A 3min

FP-FR-32-7 / 

Retina - Medical

Visual Acuity Outcomes in Dosing Subgroups of the GALILEO and COPERNICUS Studies in Patients with Macular Edema Secondary to Central Retinal Vein Occlusion

Akitaka Tsujikawa

Visual Acuity Outcomes in Dosing Subgroups of the GALILEO and COPERNICUS Studies in Patients with Macular Edema Secondary to Central Retinal Vein Occlusion

Duration 5min, Q&A 3min

FP-FR-32-8 / 

Retina - Medical

Boosted Intravitreal Injection of Bevacizumab Combined with Macular Grid Photocoagulation for Macular Edema following Branch Retinal Vein Occlusion

Daisuke Muramatsu

Boosted Intravitreal Injection of Bevacizumab Combined with Macular Grid Photocoagulation for Macular Edema following Branch Retinal Vein Occlusion

Duration 5min, Q&A 3min

FP-FR-32-9 / 

Retina - Medical

Clinical Implications of Serous Macular Edema Versus Cystoid Macular Edema in Branch Retinal Vein Occlusions

Urmil Shah

Clinical Implications of Serous Macular Edema Versus Cystoid Macular Edema in Branch Retinal Vein Occlusions

Duration 5min, Q&A 3min

FP-FR-32-10 / 

Retina - Medical

Intravitreal Ranibizumab Versus Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRANVO): A Double Masked Randomized Study

Bhavik Panchal

Intravitreal Ranibizumab Versus Bevacizumab in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRANVO): A Double Masked Randomized Study

Duration 5min, Q&A 3min

FP-FR-32-11 / 

Retina - Medical

Is Vitamin D Deficiency a Risk Factor for Retinal Venous Occlusion? A Pilot Study

Avadhesh Oli

Is Vitamin D Deficiency a Risk Factor for Retinal Venous Occlusion? A Pilot Study

Go back